HKSE - Delayed Quote HKD
HUTCHMED (0013.HK)
21.200
+0.400
+(1.92%)
At close: May 16 at 4:08:18 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
497
497
219,258
-268,599
-204,223
Investing Cash Flow
-96,060
-96,060
-291,136
296,588
-306,320
Financing Cash Flow
-30,667
-30,667
48,660
-82,763
650,028
End Cash Position
153,958
153,958
283,589
313,278
377,542
Capital Expenditure
-17,933
-17,933
-32,612
-36,664
-16,756
Issuance of Capital Stock
790
790
5,094
174
717,319
Issuance of Debt
36,199
36,199
61,705
17,753
0
Repayment of Debt
-30,592
-30,592
0
-26,923
-579
Repurchase of Capital Stock
-36,064
-36,064
-9,071
-48,084
-27,309
Free Cash Flow
-17,436
-17,436
186,646
-305,263
-220,979
12/31/2021 - 6/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3692.HK Hansoh Pharmaceutical Group Company Limited
23.450
+3.76%
1513.HK LIVZON PHARMA
26.550
-0.56%
1558.HK HEC CJ PHARM
13.240
+1.22%
2877.HK China Shineway Pharmaceutical Group Limited
7.150
+0.85%
3320.HK China Resources Pharmaceutical Group Limited
4.950
0.00%
6896.HK Golden Throat Holdings Group Company Limited
5.430
+6.26%
6185.HK CanSino Biologics Inc.
33.050
+4.92%
0460.HK SIHUAN PHARM
0.670
+1.52%